In focus · trending topic

OX-40 Receptor Therapeutics

1 stories · following the connections

OX-40 Receptor Agonist Therapeutics Pipeline to Develop More as Monoclonal Antibody: P&S Market Research

By Nasdaq OMXFeb 7, 2018, 6:48 AM UTC